FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Herrera Malaga Adolfo 		2. Issuer Name and Ticker or Trading Symbol

BENTLEY PHARMACEUTICALS INC [ BNT ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
_____ Officer (give title below)      __ X __ Other (specify below)
Managing Director European Ops
(Last)          (First)          (Middle)

BENTLEY PARK, 2 HOLLAND WAY 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/22/2008
(Street)

EXETER, NH 03833
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock $0.02 par value   5/22/2008     M    7000   (5) A $2.375   26625   D    
Common Stock, $0.02 par value   5/23/2008     M    2125   (2) A $0   28750   D    
Common Stock, $0.02 par value   5/23/2008     M    2250   (2) A $0   31000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Right to purchase   $2.375   5/22/2008     M        7000      (1) 6/15/2008   Common Stock, $0.02 par value   7000   $2.375   0   D    
Restriced Stock Units     (3) 5/23/2008     M        2125      (4)   (4) Common Stock, $0.02 par value   2125   $0   4250   D    
Restricted Stock Units     (3) 5/23/2008     M        2250      (4)   (4) Common Stock, $0.02 par value   2250   $0   6750   D    

Explanation of Responses:
( 1)  Options were granted under the terms of the Company's 1991 Stock Option Plan. Options became exercisable on 6/15/1999.
( 2)  Represents shares issued from the vesting of stock options.
( 3)  Each restricted stock unit represents a contingent right to receive one share of Bentley Pharmaceuticlas, Inc. Common Stock, $0.02 par value.
( 4)  Restricted stock units were granted under the terms of the Company's Amended and Restated 2005 Equity and Incentive Plan. Remaining units vest, and will be issued to the reporting person in three equal installments on 5/23/2009, 5/23/2010 and 5/23/2011.
( 5)  Represents the exercise of stock options previously granted to the reporting person.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Herrera Malaga Adolfo
BENTLEY PARK
2 HOLLAND WAY
EXETER, NH 03833


Managing Director European Ops

Signatures
Adolfo Herrera Malaga 5/23/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Brookfield Wealth Soluti... (NYSE:BNT)
過去 株価チャート
から 1 2025 まで 2 2025 Brookfield Wealth Soluti...のチャートをもっと見るにはこちらをクリック
Brookfield Wealth Soluti... (NYSE:BNT)
過去 株価チャート
から 2 2024 まで 2 2025 Brookfield Wealth Soluti...のチャートをもっと見るにはこちらをクリック